BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 258 filers reported holding BIONTECH SE in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $170,978,827 | -8.5% | 1,573,811 | -9.1% | 0.01% | 0.0% |
Q2 2023 | $186,836,543 | -22.1% | 1,731,090 | -10.1% | 0.01% | -28.6% |
Q1 2023 | $239,896,658 | -22.4% | 1,925,798 | -6.4% | 0.01% | -30.0% |
Q4 2022 | $309,231,325 | +51.5% | 2,058,523 | +36.1% | 0.01% | +42.9% |
Q3 2022 | $204,059,000 | -15.1% | 1,512,900 | -6.2% | 0.01% | -12.5% |
Q2 2022 | $240,407,000 | -12.5% | 1,612,383 | +0.1% | 0.01% | +14.3% |
Q1 2022 | $274,768,000 | -16.7% | 1,610,975 | +25.9% | 0.01% | -12.5% |
Q4 2021 | $329,951,000 | -18.0% | 1,279,874 | -13.2% | 0.01% | -27.3% |
Q3 2021 | $402,417,000 | +21.3% | 1,474,109 | -0.5% | 0.01% | +22.2% |
Q2 2021 | $331,654,000 | +308.9% | 1,481,390 | +99.4% | 0.01% | +350.0% |
Q1 2021 | $81,112,000 | +48.8% | 742,858 | +11.1% | 0.00% | 0.0% |
Q4 2020 | $54,499,000 | +7274.7% | 668,546 | +6163.3% | 0.00% | – |
Q3 2020 | $739,000 | +32.0% | 10,674 | +27.2% | 0.00% | – |
Q2 2020 | $560,000 | -16.2% | 8,390 | -26.7% | 0.00% | – |
Q1 2020 | $668,000 | +81.5% | 11,441 | +5.2% | 0.00% | – |
Q4 2019 | $368,000 | – | 10,872 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
Systrade AG | 50,000 | $5,432,000 | 4.70% |
Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
AtonRa Partners | 4,707 | $511,368 | 1.07% |
Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |